Pfizer Inc. (pfe)
PFE Valuation
| P/E (trailing) | 34.03 |
| P/E (forward) | 9.13 |
| EV/EBITDA | 7.93 |
| Price/Sales | 2.34 |
| Price/Book | 1.75 |
| Market cap | $149.33B |
Pfizer Inc. FAQ
What does Pfizer Inc. (PFE) do?
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiova…
What is PFE's P/E ratio?
Pfizer Inc. has a trailing P/E of 34.03× based on publicly available market data.
Does PFE pay a dividend?
Indicated dividend yield: 6.7%. Confirm ex-dates and payout history in Vest Terminal.
What sector is PFE in?
Pfizer Inc. is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is PFE's market capitalization?
Approximate market cap: $149.33B.
What are the main risks for PFE?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of PFE?
Potential positives include gross margin of 74.7% supports competitive unit economics, positive free cash flow ($12.49b).
Where can I get analyst estimates for PFE?
Consensus estimates, price targets, and detailed analyst data for Pfizer Inc. are available to Professional subscribers in Vest Terminal — not on this public summary page.